01.05.2008 | Original Articles
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2008
Einloggen, um Zugang zu erhalten